Clinical Trial Update: Humoral Response to Tick-borne Encephalitis Vaccine in Elderly [Phase 2, Phase 3]

View source ↗

Summary

This update reports humoral immune response results from phase 2 and phase 3 trials of a Tick-borne Encephalitis vaccine in elderly adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Tick-borne encephalitis vaccine (Tick-borne encephalitis vaccine)

Snippet

Sponsor: Sormland County Council, Sweden | Conditions: Tick-borne Encephalitis | Phase 2, Phase 3 | Status: COMPLETED